1. Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series. (1st January 2022) Authors: Trum, N.A.; Zain, J.; Martinez, X.U.; Parekh, V.; Afkhami, M.; Abdulla, F.; Carson, K.R.; Rosen, S.T.; Bennett, C.L.; Querfeld, C. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mogamulizumab efficacy is underscored by its associated rash that mimics cutaneous T‐cell lymphoma: a retrospective single‐centre case series. (20th October 2021) Authors: Trum, N.A.; Zain, J.; Martinez, X.U.; Parekh, V.; Afkhami, M.; Abdulla, F.; Carson, K.R.; Rosen, S.T.; Bennett, C.L.; Querfeld, C. Journal: British journal of dermatology Issue: Volume 186:Number 1(2022) Page Start: 153 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗